Ascletis Pha B
Ascletis Pharma Inc., commonly referred to as Ascletis, is a prominent biopharmaceutical company headquartered in China (CN). Founded in 2013, Ascletis has rapidly established itself in the biotechnology sector, focusing on the research, development, and commercialisation of innovative therapies for viral infections, liver diseases, and cancer. With a strong operational presence in major regions across Asia, Ascletis has achieved significant milestones, including the successful launch of its core products, which are distinguished by their advanced formulations and efficacy. The company is recognised for its commitment to addressing unmet medical needs, positioning itself as a leader in the competitive biopharmaceutical landscape. Ascletis continues to drive innovation, contributing to the global fight against serious health challenges.
DitchCarbon Score
How does Ascletis Pha B's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ascletis Pha B's score of 27 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ascletis Pha B's reported carbon emissions
In 2024, Ascletis Pha B reported total carbon emissions of approximately 284,000 kg CO2e, comprising 900 kg CO2e from Scope 1, 283,400 kg CO2e from Scope 2, and 226,700 kg CO2e from Scope 3 emissions. This marks a significant reduction from previous years, particularly in Scope 1 and Scope 2 emissions, which were 3,500 kg CO2e and 1,042,500 kg CO2e respectively in 2023, and 3,400 kg CO2e and 971,800 kg CO2e in 2022. The company has demonstrated a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. The emissions data indicates a trend towards lower emissions over the years, reflecting a proactive approach to climate responsibility. Ascletis Pha B's efforts align with industry standards for climate action, focusing on transparency and accountability in emissions reporting.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 14,630 | 0,000 | 0,000 | 000 |
| Scope 2 | 2,165,640 | 000,000 | 0,000,000 | 000,000 |
| Scope 3 | - | 000,000 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ascletis Pha B is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
